还没做过化疗，EGFR是野生型的病友一定要去做ALK的检测

jzjqian 发表于 2012-7-25 15:45

                               
登录/注册后可看大图

* c" A) W$ i$ _2 y请教，像我这样的，手术22个月了，还能去原手术医院拿到病理作EGFR检查么？

可以，但要有针对性，

请问，肺鳞癌，只做过一次化疗，骨髓抑制严重，后吃特罗凯4个月基本无效，可以参加实验组吗？

不可以了,要没做过任何治疗的,包括化疗和靶向药

Concomitant EGFR mutation and EML4-ALK gene fusion in non-small cell lung cancer.  Print this page  
: N: `% g  j0 M

Sub-category:
  g- o7 {: [# w4 ?# x1 O% a( W) cMolecular Targets
+ r+ l2 k# k$ V5 i& K3 T

Category:
Tumor Biology


Meeting:
( w6 D& F& a9 y; O! \% V( u. e2011 ASCO Annual Meeting

& ]3 \, p5 e+ ?( a# h9 ^3 _- L
8 [& e5 O- q& \9 p# Q& ~7 tSession Type and Session Title:
* f" x1 n" K& {& L$ A  `  bPoster Discussion Session, Tumor Biology


8 B# V/ k2 V6 i% f5 PAbstract No:
10517
8 q& y% z  m% h! t1 h' F: s4 a% G
) W* a( _+ |4 t5 h0 [" L0 q) d
Citation:
J Clin Oncol 29: 2011 (suppl; abstr 10517)

  C  S) G/ E' f7 w8 n8 Z( z- f& l3 [
$ c7 @: i! Q9 {Author(s):
J. Yang, X. Zhang, J. Su, H. Chen, H. Tian, Y. Huang, C. Xu, Y. L. Wu; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China; Guangdong Lung Cancer Institute, Medical Research Center of Guangdong General Hospital, Guangzhou, China; Guangdong Lung Cancer Institute, Guangzhou, China; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China
  p  Z; C1 Z/ k# y& `
  X0 Y0 p! u. c( d! G. h' v5 T9 e

Abstracts that were granted an exception in accordance with ASCO's Conflict of Interest Policy are designated with a caret symbol (^) here and in the printed Proceedings.
+ r! n/ n0 i1 V
' H$ [; h  H" X& A& S3 _Abstract Disclosures

Abstract:
; [: j  w7 h# c' D: K

2 l  i8 x8 L5 Y+ j/ {4 L1 f8 xBackground: The fusion of the anaplastic lymphoma kinase (ALK) with the echinoderm microtubule-associated protein-like 4 (EML4) and epidermal growth factor receptor (EGFR) mutations are considered mutually exclusive. Advanced non-small cell lung cancer (NSCLC) patients with EML4-ALK did not benefit from EGFR tyrosine kinase inhibitors (TKIs). Methods: Multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) followed by sequencing was performed for EML4-ALK fusion status detection. EGFR and KRAS mutations were determined by direct DNA sequencing. Positive results of EML4-ALK fusion were also confirmed by RACE-coupled PCR sequencing. Results: From April 2010 to January 2011, 412 patients (398 with NSCLC; 14 with SCLC) were tested for mutation status of EGFR, KRAS and EML4-ALK respectively. Frequency of EML4-ALK fusion was 10.6% (42/398) in NSCLC patients. No patients with SCLC were found to have positive EML4-ALK fusion. Frequency of concomitant EGFR and EML4-ALK gene mutations was 1.0% (4/398) in NSCLC patients, and their variants of EML4-ALK gene mutations were Variant 1 (3 patients) and Variant 6 (1 patient); being never smokers, all of them were diagnosed with advanced (3 with stage †W and 1 with stage IIIB) adenocarcinoma harbouring wild type KRAS. Two female stage †W patients with double gene mutations (1 with L858R and Variant 1; 1 with exon19 deletion and Variant 6) received first-line gefitinib which is one kind of EGFR TKIs and achieved partial response. Conclusions: Though being rare events, NSCLC patients harbouring concomitant EGFR mutation and EML4-ALK gene fusion are sensitive to first-line EGFR TKIs. Whether they could also benefit from ALK inhibition after failure to EGFR TKIs warranted further investigation.

+ q; D8 ?% W% b, i" |, {' Q

由吴一龙教授牵头的A80810029临床试验上周启动，初诊未治疗的晚期肺腺癌患者检测到ALK阳性，可参加一线crizotinib 对比力比泰+卡铂的临床研究，药物全部免费，即使分配到力比泰组，疾病进展之后可免费获得crizotinib.

没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

boeun 发表于 2012-11-18 16:37

                               
登录/注册后可看大图

5 v) K+ t, `' ?没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

  @( T) r6 C: V化疗过的没机会了

平安！ 发表于 2012-7-20 11:20

                               
登录/注册后可看大图

" u' [2 y7 V) q  i6 f& }易瑞沙、特罗凯有效的病人基本上可以断定ALK（-）。极其罕见EGFR、ALK同时突变的。
+ X# J4 k% r' H' A+ I; HALK一个指标医院要900多 ...

平安，真的没有希望吗？我弟弟虽然特罗凯有效，但是ＥＧＦＲ是野生型，不是突变啊。有没有必要去检测ＡＬＫ呢？

) H4 t9 i- R8 l: p: d现在病情进展，快没招儿了。

好像想加入挺困难的

小地方没条件做啊